|
Vincent Brichard, MD, PhD
GlaxoSmithKline Biologicals
Cedrik M. Britten, MD
Association for Cancer Immunotherapy (CIMT)
Lisa H. Butterfield, PhD
University of Pittsburgh
Mary L. (Nora) Disis, MD
University of Washington
Bernard A. Fox, PhD
Earle A. Chiles Research Institute
Mark W. Frohlich, MD
Dendreon Corporation
Jérôme Galon, PhD
INSERM, Integrative Cancer Immunology Laboratory,
Cordeliers Research Center
Howard L. Kaufman, MD
Rush University Medical Center
Samir N. Khleif, MD
National Cancer Institute (CCR)
John M. Kirkwood, MD
University of Pittsburgh Cancer Institute
Peter P. Lee, MD
Stanford University
|
Paul V. Lehmann, MD, PhD
Cellular Technology Limited
Diane Longo, PhD
Nodality, Inc.
Holden T. Maecker, PhD
Stanford University Medical Center
Francesco Marincola, MD
National Institutes of Health (CC, DTM)
Daniel Normolle, PhD
University of Pittsburgh Cancer Institute
Thomas R. O'Brien, MD
National Cancer Institute, Division of Cancer Epidemiology and Genetics
Raj K. Puri, MD, PhD
Food and Drug Administration, CBER
Nicholas P. Restifo, MD
National Cancer Institute
Samuel C. Silverstein, MD
Columbia University
David Stroncek, MD
Clinical Center, National Institutes of Health
|
|